Each of our data clients are different. If you have a specific brief for a medicine (whether it be new, approved, generic or biosimilar) and you need a bespoke approach please talk to us. We enjoy being involved from the launch stage of a medicine and in adding value in segmenting the patient population through both conversational and digital patient group work on Medsmart®. We will work deeply as your partner to help find your patient insights and build a long term approach to patient centricity.